Extracellular Vesicle-DNA: The Next Liquid Biopsy Biomarker for Early Cancer Diagnosis?

SIMPLE SUMMARY: Each human cancer is a specific disease, but all cancers share the necessity of an early diagnosis for providing the optimal outcome for the patient. Liquid biopsy in blood, as a substitute to invasive tissue biopsies, brought the first important breakthrough for cancer diagnosis. Th...

Descripción completa

Detalles Bibliográficos
Autor principal: Tatischeff, Irène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000627/
https://www.ncbi.nlm.nih.gov/pubmed/36900248
http://dx.doi.org/10.3390/cancers15051456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000627/
https://www.ncbi.nlm.nih.gov/pubmed/36900248
http://dx.doi.org/10.3390/cancers15051456

Ejemplares similares